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T helper 1 (Th1) cell-associated immunity exacer-
bates ileitis induced by oral Toxoplasma gondii infec-
tion. We show here that attenuated ileitis observed
in interleukin-22 (IL-22)-deficient mice was associ-
ated with reduced production of Th1-cell-promoting
IL-18. IL-22 not only augmented the expression of
Il18 mRNA and inactive precursor protein (proIL-18)
in intestinal epithelial cells after T. gondii or Citro-
bacter rodentium infection, but also maintained the
homeostatic amount of proIL-18 in the ileum. IL-22,
however, did not induce the processing to active
IL-18, suggesting a two-step regulation of IL-18
in these cells. Although IL-18 exerted pathogenic
functions during ileitis triggered by T. gondii, it was
required for host defense against C. rodentium.
Conversely, IL-18 was required for the expression
of IL-22 in innate lymphoid cells (ILCs) upon
T. gondii infection. Our results define IL-18 as an
IL-22 target gene in epithelial cells and describe a
complex mutual regulation of both cytokines during
intestinal infection.
INTRODUCTION
Infection with the protozoan parasite Toxoplasma gondii
(T. gondii) elicits a Th1-cell-type immune response (Munoz
et al., 2011). Although oral or intraperitoneal infection with a
low inoculum (<20 cysts) generates a protective Th1 cell
response (Munoz et al., 2011; Suzuki et al., 1988), oral infection
with a higher inoculum (50–100 cysts) results in a detrimental Th1
cell response characterized by the development of severe small
intestinal necrosis due to excessive production of pro-inflamma-tory mediators (Liesenfeld et al., 1996). Th1-cell-associated cy-
tokines including interleukin-12 (IL-12), interferon-g (IFN-g),
and tumor necrosis factor-a (TNF-a) and infiltration of neutro-
phils to the site of infection are responsible for the immunopa-
thology after high-dose oral infection (Bennouna et al., 2003;
Heimesaat et al., 2006; Liesenfeld et al., 1996, 1999). Among
these cytokines, IFN-g is mainly produced by T cells as well as
NK cells (Liesenfeld et al., 1996, 1999).
IL-18 was originally identified in its role of promoting Th1 cell
development and IFN-g production (Okamura et al., 1995).
Although it does not play a dominant protective role in the low-
dose model (Cai et al., 2000), IL-18 contributes to the develop-
ment of small intestinal immunopathology after oral high-dose
infection of T. gondii, partially through the induction of IFN-g pro-
duction (Vossenka¨mper et al., 2004). Previous studies suggest
that Il18 mRNA as well as proIL-18 are constitutively produced
by myeloid cells and intestinal epithelial cells (Kolinska et al.,
2008). The generation of the active form of IL-18 requires inflam-
masome activation and caspase-mediated enzymatic cleavage
(Gu et al., 1997).
Recently, IL-22 and IL-23 have been shown to exert patho-
genic functions in T. gondii-induced ileitis (Mun˜oz et al., 2009).
IL-22 belongs to the IL-10 cytokine family and has been
described to induce antimicrobial, tissue-protective, and
wound-healing responses from epithelial cells during infection
and inflammation (Eidenschenk et al., 2014; Ouyang et al.,
2011). The induction of IL-22 in the ileum during T. gondii infec-
tion is dependent on the IL-23 pathway. IL-22 is produced by
several T helper cell and innate lymphoid cell (ILC) subsets
(Rutz et al., 2013). The receptor of IL-22 is expressed mainly
on tissue epithelial cells, but not on leukocytes (Ouyang et al.,
2011).
The mechanisms of how IL-22 contributes to the Th1-cell-
mediated pathology in the high-dose model of T. gondii infection
remain unclear. Here we report that IL-18 production by epi-
thelial cells observed in wild-type mice during T. gondii infe-
ction was abolished in IL-22-deficient mice. IL-22 induced theImmunity 42, 321–331, February 17, 2015 ª2015 Elsevier Inc. 321
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Figure 1. IL-18 Induction in the Ileum during
T. gondii Infection Is Diminished in IL-22-
Deficient Mice
(A) Heat map of microarray analysis of ileal RNA
isolated from wild-type and IL-22-deficient mice
5 days after T. gondii infection. n = 5 mice per
group.
(B) IL-18 mean fluorescence intensity (MFI) from
the analysis shown in (A).
(C) Il18 mRNA expression of ileal biopsies of wild-
type and IL-22-deficient mice 7 days p.i. Results
are presented relative to the expression of Hprt.
(D) IL-18 concentration in overnight ileal culture
supernatants of naive and infected wild-type and
IL-22-deficient mice 7 days p.i. by ELISA. One
representative of two independent experiments is
shown, n = 6mice per group. Statistics are given as
mean ± SEM and p values were determined by
Student’s t test. *p < 0.05, ***p < 0.001.
(E) Immunohistochemical staining of IL-18 in ileal
histological sections of wild-type and IL-22-defi-
cient mice 7 days p.i. Scale bars represent 100 mm
(3100) and 20 mm (3400).
See also Figure S1.expression of Il18 mRNA and full-length proIL-18 from intestinal
epithelial cells. IL-22 was also required to maintain homeostatic
expression of proIL-18 in the small intestine of naive mice. This
regulation of proIL-18 by IL-22 was independent of the inflam-
masome and MyD88 pathways. During T. gondii infection,
IL-18 was also required for optimal IL-22 production in the ileum.
IL-18 synergized with IL-23 to elicit optimal IL-22 production
from ILCs as well as T helper cell subsets. While amplifying a
pathogenic positive feedback loop during T. gondii infection,
IL-22 also enhanced IL-18 expression from epithelial cells in
the colon as part of the protective host defense during
C. rodentium infection. In summary, our findings establish Il18
as a target gene of IL-22 in intestinal epithelial cells and uncover
complex regulatory links between both cytokines during intesti-
nal infection.
RESULTS
IL-18 Production in the Ileum Is Diminished in
IL-22-Deficient Mice during T. gondii Infection
To investigate the pathogenic mechanisms of IL-22 after oral
infection with high dose of T. gondii (Mun˜oz et al., 2009), the
expression profile of ilea at day 5 after infection was analyzed
(Figure 1A). Il18was one of the top genes significantly downregu-
lated in IL-22-deficient mice (Figures 1A–1C), which was further
confirmed by protein analysis from overnight ileal cultures (Fig-
ure 1D). Immunohistochemical analysis of ileal sections identi-
fied a dominant IL-18 staining in the small intestinal epithelium
as well as scattered IL-18+ cells, presumably monocytes and
macrophages in sections of the lamina propria (Figure S1). Dras-322 Immunity 42, 321–331, February 17, 2015 ª2015 Elsevier Inc.tically reduced IL-18 staining was found in
the small intestinal epithelium of infected
IL-22-deficient mice compared to wild-
type mice 7 days after T. gondii infection
(Figure 1E).These findings collectively suggested that IL-22 was indis-
pensable for promoting IL-18 production in the small intestine
during T. gondii-induced ileitis. Given the fact that blocking
IL-18 alleviated ileitis and IFN-g expression during T. gondii
infection, IL-18 became the main candidate downstream of IL-
22 to prompt Th1-cell-mediated pathology (Mun˜oz et al., 2009;
Vossenka¨mper et al., 2004).
Reduced IFN-g Production and Neutrophil Recruitment
in the Small Intestine of IL-22-Deficient Mice during
T. gondii Infection
Consistent with the diminished IL-18 production in IL-22-defi-
cient mice during T. gondii infection, IFN-g induction, which
peaked between days 5 and 7 after infection in ilea from wild-
type mice, was drastically reduced in the ilea of IL-22-deficient
mice (Figure 2A). Flow cytometric analysis of small intestinal lam-
ina propria mononuclear cells and intraepithelial lymphocytes
(IELs) revealed that both IFN-g+CD8 T cells and IFN-g+CD8+
T cell populations including IELs were reduced in IL-22-deficient
mice compared to wild-type mice (Figures 2B, 2C, and S2A).
Furthermore, we noticed a reduction in NK1.1+ cells, which
also contribute to IFN-g production (Hunter et al., 1994), in the
mesenteric lymph nodes of infected IL-22-deficient mice as
compared to wild-type controls (Figures S2B and S2C).
Next, we observed a reduction in frequencies of CD11b+Gr1+
cells in the small intestinal lamina propria of IL-22-deficient mice
ascompared to infectedwild-typemice7daysafter infection (Fig-
ures 2Dand2E). Furthermore, although thenumbersofmyeloper-
oxidase positive (MPO+) lamina propria cells were significantly
increased in infected wild-type mice (Figures 2F and 2G), this
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Figure 2. IFN-g Production and Neutrophil
Recruitment Is Reduced in the Small Intes-
tine of IL-22-Deficient Mice during the Devel-
opment of T. gondii-Induced Ileitis
(A) IFN-g concentration in overnight ileal culture
supernatants of naive and infected wild-type and
IL-22-deficient mice 3, 5, and 7 days p.i. by ELISA.
n = 6 mice per group.
(B–E) Representative data of flow cytometric anal-
ysis of cells isolated from small intestinal lamina
propria of one infected wild-type and one IL-22-
deficient mouse 7 days p.i. stained for CD8 and
IFN-g (B and C) or for CD11b and Gr1 (D and E).
Quantification of the data of one representative of
two independent experiments is shown in (C) and
(E), n = 6 mice per group.
(F and G) Immunohistochemical staining of MPO in
ileal sections of one naive and one infected wild-
type and IL-22-deficient mouse 7 days p.i. Scale
bars represent 100 mm (3100) and 20 mm (3400).
Quantification of the data of one representative of
two independent experiments is shown in (G), n = 6
mice per group.
Statistics are given as mean ± SEM and p values
were determined by Student’s t test. **p < 0.01;
***p < 0.001. See also Figure S2.increasewas not observed in infected IL-22-deficientmice. Naive
IL-22-deficient mice displayed similar numbers of MPO+ cells as
naive control mice (Figures 2F and 2G). Taken together, these
data suggested that the decrease of IL-18 expression might
contribute to the reduced Th1-cell-mediated inflammation in
IL-22-deficient mice after oral infection with T. gondii.
IL-22 Induces Il18 mRNA and proIL-18 but Not Mature
IL-18 Expression from Epithelial Cells in the Ileum
Because IL-22 acts on intestinal epithelial cells, we hypothesized
that IL-22 could regulate the expression of IL-18 from these cells.
Indeed, IL-22 induced Il18 mRNA expression from wild-type
small-intestine-derived epithelial organoids but not IL-22R1-
deficient organoids (Figure 3A). Furthermore, elevated Il18, butImmunity 42, 321–331,not Il1b, mRNA was observed in the ileum
as early as 4 hr after IL-22-Fc administra-
tion in vivo (Figures 3B and S3A). Immuno-
histochemical staining of IL-18 confirmed
its epithelial origin (Figure 3C). Next, we
asked whether the increased Il18 mRNA
after IL-22 stimulation resulted in only
proIL-18 or whether IL-22 also partici-
pated in the generation of active IL-18.
First, proIL-18 was expressed in isolated
small intestinal epithelial cells (Figure 3D).
Under this isolation condition, active IL-18
was generated dependent on caspase-1
and ASC, but not on the NLRP3 inflamma-
some complex (Figures 3D and S3B).
However, we believed that this maturation
of IL-18 by the inflammasome was the
result of the mechanical stress imposed
on the intestinal epithelial cells during theharvesting procedure, because when we snap-froze ileal sam-
ples isolated from wild-type mice treated with IL-22-Fc, we de-
tected the induction of only proIL-18, not active IL-18 (Figure 3E).
With the caveat that the ex vivo processing of ileal tissues could
activate IL-18, IL-22 also stimulated increased secretion of
active IL-18 from ex vivo ileal cultures (Figure 3F). Furthermore,
IL-22 induced Il18 message and proIL-18 expression in the ilea
of IL-22-deficient but not of IL-22R1-deficient mice (Figures 3G
and S3C). We sometimes noticed a faint band of lower molecular
size (Figure 3E, arrow) after IL-22 treatment. This band had a
lower molecular weight than active IL-18 from macrophages
stimulated with LPS and nigericin (Figure 3H). Therefore, this
band probably represented a degraded form of IL-18 resulting
from the accumulation of proIL-18 after IL-22 treatment. InFebruary 17, 2015 ª2015 Elsevier Inc. 323
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Figure 3. IL-22 Directly Induced IL-18
Expression in the Ileum
(A) Il18 mRNA expression in organoid cultures
from ileum isolated from wild-type and IL-22R1-
deficient mice, stimulated with PBS or rIL-22
(100 ng/ml) for the indicated time.
(B) Il18mRNA expression in the ileum of wild-type
mice injected with control IgG or IL-22-Fc for the
indicated amounts of time. n = 3 mice per group.
(C) Immunohistochemical staining of IL-18 in ileal
histological sections of wild-type mice injected
with PBS or IL-22-Fc at 24 hr p.i. Scale bars rep-
resents 100 mm (3100).
(D) IL-18 expression in epithelial cells of duo-
denum, jejunum, and ileum of wild-type and Cas-
pase-1-, Nrlp3-, and ASC-deficient mice after
isolation by scraping.
(E) IL-18 expression in the ileum of wild-type mice
injectedwithcontrol IgGor IL-22-Fc for the indicated
time. The arrow shows a degraded IL-18 band.
(F) IL-18 concentrations in ileal ex vivo cultures of
naive wild-type mice in the presence or absence
of rIL-22 (100 ng/ml) for 2 and 6 hr and measured
by ELISA.
(G) IL-18 expression in the ileum of IL-22- and IL-
22R1-deficient mice and their respective wild-type
littermates 56 hr p.i. with IL-22-Fc.
(H) Wild-type mice were treated with IL-22-Fc and
proteins were extracted from the ileum (left) and
run side-by-side with supernantants of macro-
phages stimulated with LPS and nigericin (right) as
a standard method to induce the processed active
IL-18. Molecular weights are indicated.
(I and J) Il18 mRNA (I) and IL-18 protein (J)
expression in the ileum of wild-type and caspases
1 and 11 double-deficient and ASC-deficient mice
56 hr p.i. with IL-22-Fc or control IgG. n = 3 mice
per group. The arrow shows the degraded IL-18
band. mRNA results are presented relative to the
expression of Rpl19. Actin is the protein loading
control.
Statistics are given as mean ± SEM and p values
were determined by Student’s t test. *p < 0.05,
**p < 0.005, ***p < 0.001. Data shown are repre-
sentative of two independent experiments. See
also Figure S3.support of this notion, this band was present even in protein
samples from caspase 1/11-double-deficient and ASC-deficient
mice treated with IL-22-Fc (Figures 3I and 3J). Notably, the in-
duction of proIL-18 by IL-22-Fc did not depend on inflamma-
some and caspase activation (Figures 3I and 3J).
In summary, these data identified IL-22 as a cytokine promot-
ing the expression of Il18 mRNA and proIL-18, but not the pro-
cessed IL-18 from small intestinal epithelial cells. This increased
proIL-18 storage could be a unique mechanism to prime intesti-
nal epithelial cells for subsequent signals such as infection,
stress, or damage, which are known to rapidly activate the in-
flammasome and trigger the release of functional IL-18 (Ewald
et al., 2014).
IL-22 Plays an Essential Role in Maintaining
Homeostatic proIL-18 Expression in the Ileum
The reduction in IL-18, both mRNA and protein, in the ileum of
naive IL-22-deficient mice prompted us to investigate a potential324 Immunity 42, 321–331, February 17, 2015 ª2015 Elsevier Inc.regulation of IL-18 expression by IL-22 in naivemice (Figures 2D,
3G, and S3C). Il18 mRNA and proIL-18 protein were constitu-
tively expressed in ileum, colon, spleen, and lung of wild-type
mice (Figures 4A and 4B). Although there were no differences
in colon, spleen, and lung, homeostatic expression of Il18
mRNA and proIL-18 were significantly reduced in the ileum of
IL-22- and IL-22R1-deficient mice compared to wild-type con-
trols. Furthermore, ileal tissues from wild-type mice cultured
ex vivo secreted markedly higher amounts of IL-18 than those
from IL-22-deficient or IL-22R1-deficient mice (Figure 4C).
When compared to colon, the ilea of naivemice had higher ho-
meostatic Il22 expression (Figure 4D; Sonnenberg et al., 2012).
Reg3b and Reg3g were also highly expressed in small intestine
but not in colon of wild-type mice (Figure S4A), and their expres-
sion in small intestine was significantly reduced in IL-22- and IL-
22R1-deficient mice. In contrast, proIL-18 expression in the ilea
of IL17Rc-deficient, IL-1R-deficient, caspase 1/caspase 11 dou-
ble-deficient, and ASC-deficient mice was not reduced (Figures
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Figure 4. Homeostatic proIL-18 Expression
Is Specifically Reduced in the Ileum of
Mice Deficient in IL-22 or Its Receptor
(A and B) Ex vivo Il18 mRNA (A) and proIL-18
expression (B) in the ileum, colon, spleen, and lung
of naive IL-22- and IL-22R1-deficient mice and
their respective wild-type littermates. n = 3 mice
per group.
(C) IL-18 production in the supernatant of overnight
ileal cultures from naive IL-22- and IL-22R1-defi-
cient mice and their respective wild-type litter-
mates measured by ELISA.
(D) Ex vivo Il22 mRNA expression in the ileum and
colon of naive wild-type mice. n = 3 mice per
group. mRNA results are presented relative to the
expression of Rpl19. Actin is the protein loading
control.
Statistics are given as mean ± SEM and p values
were determined by Student’s t test. *p < 0.05,
***p < 0.001. Data shown are representative of two
independent experiments. See also Figure S4.S4B and S4C), despite the fact that these pathways are all re-
ported to regulate epithelial biology. Thus, our data point toward
a unique role for IL-22 inmaintaining the homeostasis of proIL-18
in the ileum.
IL-22-Mediated IL-18 Induction Is Independent of
Luminal Microbiota
IL-22 is essential in controlling both pathogenic and commensal
bacteria in the intestine (Eidenschenk et al., 2014; Zenewicz
et al., 2013). Changes in microbiota in IL-22-deficient mice might
contribute independently to the expression of proIL-18 in intes-
tinal epithelial cells. Indeed, bacterial products such as LPS or
flagellin enhanced proIL-18 expression in the small intestine of
wild-type mice (Figure 5A). However, in IL-22-deficient mice,
LPS and flagellin failed to induce proIL-18 expression (Figure 5A).
Conversely, IL-22 could induce Il18 mRNA and proIL-18 protein
inMyD88-deficient mice (Figures 5B and 5C) and germ-freemice
(Figures 5D and 5E). These data support that IL-22 regulated
IL-18 expression independent of luminal microbiota.
Previous studies indicated that the change in intestinal micro-
biota could influence the host immune response during oral
T. gondii infection (Heimesaat et al., 2006, 2007). In order to
study the contribution of the microbiota to the induction of
IL-18 during T. gondii infection, we treated IL-22-deficient and
wild-type mice with an antibiotic cocktail to eradicate the cultur-
able intestinal microflora and then reconstituted these mice withImmunity 42, 321–331,an identical microbiota by oral gavage of
feces suspensions of SFP wild-type
C57BL/6 animals for 3 consecutive days
as previously described (Heimesaat
et al., 2006). This treatment resulted in a
very similar intestinal microbiota compo-
sition in these mice, analyzed 3 weeks
after reconstitution (Figure S5). After oral
infection with T. gondii, induction of
IL-18 mRNA and protein were readily de-
tected in the ileum of wild-type mice, but
not in IL-22-deficient mice (Figures 5Fand 5G). Taken together, these data suggest that the induction
of IL-18 by IL-22 in the ileumduring T. gondii infection is indepen-
dent of other inflammatory pathways and alterations in the
microbiota.
IL-18 Is Required for the Upregulation of IL-22 during
T. gondii Infection
One important pathogenic role of IL-18 in T. gondii infection is to
promote IFN-g production (Vossenka¨mper et al., 2004). By us-
ing IL-18- and MyD88-deficient mice, both of which abolished
activity of IL-18 (Adachi et al., 1998; Barton and Medzhitov,
2003), we confirmed that ileal inflammation and necrosis were
significantly alleviated in these mice (Figure S6A). Amounts of
both IL-22 and IL-18 were significantly reduced in MyD88-defi-
cient mice, consistent with the fact that MyD88 is required for
TLR signaling and for the induction of IL-23 (Figures S6B and
S6C). However, IL-22 expression was significantly diminished
in IL-18-deficient mice whereas IL-1b and IL-23 were not
affected (Figures 6A, S6D, and S6E). Consistently, IL-22+CD4+
T cells in the small intestinal lamina propria were significantly
reduced 7 days after infection in IL-18-deficient compared to
wild-type mice (Figures S6F and S6G). These results suggested
that in addition to promoting IFN-g production, IL-18 was indis-
pensable for IL-22 production in the ileum during T. gondii infec-
tion. Indeed, IL-22 production was significantly upregulated in
supernatants of ileal cultures from wild-type but not fromFebruary 17, 2015 ª2015 Elsevier Inc. 325
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Figure 5. IL-22 Induced IL-18 Independently
of MyD88 and the Microbiota
(A) proIL-18 expression in the ileum of wild-type
and IL-22-deficient mice 24 hr p.i. with flagellin,
LPS, or PBS as control.
(B and C) Il18 mRNA (B) and IL-18 protein
expression (C) from ilea of wild-type and MyD88-
deficient mice injected with control IgG or IL-22-Fc
for the indicated amount of time. One represen-
tative of two independent experiments is shown,
n = 3 mice per group.
(D and E) Il18 mRNA (D) and IL-18 protein
expression (E) from ilea of germ-free mice injected
with control IgG or IL-22-Fc for 60 hr. n = 5 mice
per group.
(F and G) Wild-type and IL-22-deficient mice were
depleted of their gut flora with an antibiotic cocktail
and subsequently reconstituted with microbiota of
SFP wild-type C57BL/6 animals for 3 consecutive
days. These mice were then infected with 100
cysts of T. gondii 6 days p.i. Il18 mRNA (F) and
IL-18 protein (G) were measured in the ileum of
reconstituted wild-type and IL-22-deficient mice.
n = 6 mice per group. mRNA results are presented
relative to the expression of Rpl19. Actin is the
protein loading control.
Statistics are given as mean ± SEM and p values
were determined by Student’s t test. *p < 0.05.
Data shown are representative of two independent
experiments. See also Figure S5.MyD88-deficient mice upon stimulation with recombinant IL-18
(Figure 6B). Furthermore, Il22 mRNA was induced in the ileum
as early as 1 hr and peaked after 4 hr after rIL-18 treatment
in vivo (Figure 6C). Serum IL-22 peaked 4 hr after IL-18 treat-
ment (Figure 6D). Thus, IL-18 induced IL-22 in the small intes-
tine both in vitro and in vivo.
CD4+ T cells and ILCs are the known dominant sources of
IL-22. These cells are present at normal frequency in IL-18-defi-
cient mice (data not shown) despite a reduction in IL-22 produc-
tion in thesemice. In vitro, IL-18 enhanced IL-22 production from
wild-type but not from IL-18R-deficient Th22 cells (Figure 6E).
IL-18 is known to synergize with other cytokines such as IL-12
to promote IFN-g production from Th1 cells (Yang et al., 1999).
We found that IL-18 functioned in synergy with IL-23 to induce
IL-22 production from both Th22 and Th17 cells but not Th1 cells
even in the absence of T cell receptor (TCR) activation (Figure 6F).
Similarly, IL-18 synergized with IL-23 to enhance IL-22 produc-
tion from splenocytes from Rag2-deficient mice that have ILCs
(but no B and T cells), but not from Rag2/gc-double-deficient
mice (which lack B cells, T cells, and ILCs) (Figure 6G). The syn-
ergistic induction of IL-22 by IL-18 was further confirmed in pu-
rified ILCs (Figure 6H). In order to identify the dominant cellular
source of IL-22 specifically during T. gondii infection, wild-
type, Rag2-deficient, and Rag2/gc-double-deficient mice were
infected. IL-22 induction after infection was maintained in326 Immunity 42, 321–331, February 17, 2015 ª2015 Elsevier Inc.Rag2/ mice, suggesting that T cells
were dispensable for IL-22 production in
this model. Instead, drastic reduction of
IL-22 was observed in the Rag2/gc-dou-
ble-deficient mice, identifying ILCs asthe dominant source of IL-22 in the ileum during T. gondii infec-
tion (Figure 6I).
In conclusion, these results demonstrated that IL-18 was
required for IL-22 production in the small intestine after
T. gondii infection. Their mutual regulation points to a previously
unknown feedback loop that promotes small intestinal inflamma-
tion via the induction of downstream effectors, such as IFN-g
production as well as neutrophil and NK cell recruitment.
IL-18 Is Induced by IL-22 in the Colon and Contributes to
Host Defense against Citrobacter rodentium
Finally, we asked whether IL-22 could also promote IL-18
expression from intestinal epithelial cells under other inflamma-
tory conditions. Although IL-22 was not required to maintain ho-
meostatic expression of IL-18 in the colon (Figures 4A and 4B),
in vivo administration of IL-22-Fc further increased IL-18 expres-
sion, both mRNA and protein, in this tissue (Figures 7A and 7B).
Previous studies have established an essential role of IL-22 in
host defense against C. rodentium infection. In this model, the
expression of Il22 in the colon peaks around day 4 (Zheng
et al., 2008) whereas the induction of Il18 peaked around
days 5 and 6 (Figure 7C). Importantly, Il18 induction after
C. rodentium infection was also dependent on IL-22 (Figure 7D).
To address the role of IL-18 in this model, IL-18-deficient mice
were infected with C. rodentium. IL-18-deficient mice showed
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Figure 6. IL-18 Was Required for IL-22 Pro-
duction from ILCs in the Ileum during
T. gondii Infection
(A) IL-22 production measured by ELISA in the
supernatant of ex vivo overnight ileal culture of
wild-type and IL-18-deficient mice infected with
T. gondii at day 7 p.i. One representative of two
independent experiments is shown, n = 5 mice per
group.
(B) IL-22 concentration in ex vivo overnight
ileal cultures of naive wild-type and MyD88-defi-
cient mice in the presence or absence of rIL-18
(10 ng/ml) for 36 hr. One representative of two in-
dependent experiments is shown, n = 6 mice per
group.
(C) Il22 mRNA expression in ilea of wild-type mice
injected with 30 mg of rIL-18 for the indicated time
points. mRNA results are presented relative to the
expression of Rpl19.
(D) IL-22 expression measured by ELISA in the
serum of wild-type mice injected with 30 mg of
rIL-18 for the indicated time points.
(E) IL-22 concentrations in the supernatant from
naive CD4+ T cells isolated from wild-type and IL-
18R-deficient mice, stimulated with anti-CD3 plus
anti-CD28 under Th22 cell conditions (IL-6, anti-
TGF-b) for 3 days.
(F) Naive CD4+ T cells were stimulated with anti-
CD3 plus anti-CD28 under Th1 (anti-IL-4, IL-12),
Th22 (IL-6, anti-TGF-b), or Th17 cell-associated
conditions (IL-6, TGF-b) for 3 days. The cells were
then rested for 3 days and restimulated in the
presence or absence of rIL-18 (20 ng/ml), rIL-23
(20 ng/ml), or both. IL-22 concentrations were
measured in the supernatants 48 hr after restim-
ulation. n = 3 mice per group. One representative
of three independent experiments is shown.
(G and H) IL-22 concentrations were measured by
ELISA in supernatants of (G) splenocytes from
Rag2-deficient and Rag2/gc-double deficient mice
or (H) ILCs isolated from the small intestine of Rag2-deficient mice that were stimulated in presence or absence of rIL-18 (20 ng/ml), rIL-23 (20 ng/ml), or both for
2 days. n = 3 mice per group. One representative of two independent experiments is shown.
(I) Il22 mRNA expression in ilea of wild-type, Rag2-deficient, and Rag2/gc-deficient mice 6 days after infection with T. gondii. n = 6 mice per group.
Statistics are given as mean ± SEM and p values were determined by Student’s t test. **p < 0.01, ***p < 0.001. See also Figure S6.significant weight loss between days 4 and 15 compared to wild-
type controls (Figure 7E). About 40% of the mice succumbed
by day 10 after infection (Figure 7F). The phenotype observed
in IL-18-deficient mice, even though it was milder than in IL-
22-deficient mice, suggested that the IL-18 pathway is part of
the host defense against C. rodentium infection downstream of
IL-22.
DISCUSSION
IL-18 can exert both protective and pro-inflammatory functions
in the intestine (Dinarello, 2009). During chronic and severe coli-
tis, IL-18 produced by infiltratingmacrophages and lymphocytes
intensifies Th1-cell-mediated immunity and inflammation (Chi-
kano et al., 2000). In contrast, IL-18 serves as a protective factor
during the early, acute phase of mucosal immune responses
when intestinal epithelial cells are the primary source of IL-18 (Ta-
kagi et al., 2003; Zaki et al., 2010). Similarly, IL-22 can elicit both
pro-inflammatory and tissue-protective functions in vivo. Duringinfection with extracellular bacteria or yeast or during acute in-
flammatory responses, IL-22 promotes epithelial innate immunity
and maintains epithelial cell barrier integrity (Ouyang et al., 2011;
Sonnenberg et al., 2011; Zheng et al., 2008). On the other hand,
IL-22 has been reported to induce pro-inflammatory effects on
various epithelial cells. For instance, IL-22 acts downstream of
IL-23 to contribute to several key pathogenic features of psoriatic
skin (Sa et al., 2007; Zheng et al., 2007). The pro-inflammatory
functions of IL-22 are largely dependent on the presence of other
pro-inflammatory cytokines (Sonnenberg et al., 2010), suggest-
ing that the protective versus pathogenic role of IL-22 probably
depends on the inflammatory context, including the amount of
IL-22 present, the kinetics of expression, and the synergy with
different cytokines during the inflammatory response as well as
the tissue involved. Our current study further reinforces the
notion that both IL-18 and IL-22 can act as a double-edged
sword. Although both cytokines provide protective immunity
in the colon during C. rodentium infection, they form a unique
inflammatory feedback loop to amplify Th1-cell-mediatedImmunity 42, 321–331, February 17, 2015 ª2015 Elsevier Inc. 327
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Figure 7. IL-22 Enhances IL-18 Expression
in the Colon after C. rodentium Infection
(A and B) Il18 mRNA (A) and IL-18 protein (B)
expression from colons of wild-type mice injected
with control IgG or IL-22-Fc for the indicated
amount of time. One representative of two inde-
pendent experiments is shown, n = 5 mice per
group.
(C) Il18 mRNA from colons of naive and infected
wild-type mice at the indicated days after infection
with C. rodentium. n = 4 mice per group.
(D) Il18 mRNA from colons of naive and infected
wild-type and IL-22-deficient mice 6 days p.i. with
C. rodentium. One representative of two inde-
pendent experiments is shown, n = 6 mice per
group.
(E and F) Weight loss (E) and survival (F) of wild-
type and IL-18-deficient mice after infection with
C. rodentium. n = 10 mice per group.
(A, C, D, F) Statistics are given as mean ± SEM and
p values were determined by Student’s t test.
(E) Statistics are given as mean ± SEM and p
values were determined by ANOVA analysis.
*p < 0.05, ***p < 0.001.immunity and trigger ileal inflammation and necrosis during high-
dose oral infection of T. gondii.
The major cellular sources of IL-18 include myeloid cells and
epithelial cells (Egan et al., 2011). Although activation of certain
innate immune signaling receptors enhances IL-18 transcription
in myeloid cells, IL-18 is generally considered to be constitutively
expressed and stored as intracellular proIL-18 protein in most
other cells (Kolinska et al., 2008; Nakanishi et al., 2001). Pro-in-
flammatory signals, through the activation of inflammasomes
and caspases, trigger the proteolytical processing of proIL-18
to its active form, which is subsequently secreted by cells
through a non-classical secretion pathway (Dinarello, 2009).
However, there is little data on the regulation of proIL-18 in
epithelial cells. Our study describes a cytokine pathway, in which
IL-22 directly regulates the transcription and expression of
proIL-18 in intestinal epithelial cells. The induction of proIL-18
in epithelial cells by IL-22 is independent of MyD88, the inflam-
masome, caspase pathways, and the intestinal microflora. This
regulatory pathway not only contributes to small intestine inflam-
mation during T. gondii infection, but more importantly it is also
indispensible for mucosal host defense in the colon during
C. rodentium infection. Furthermore, we showed that IL-22 is
absolutely required for the maintenance of proIL-18 expression328 Immunity 42, 321–331, February 17, 2015 ª2015 Elsevier Inc.in small intestinal epithelial cells, but not
in other mucosal epithelial organs, such
as lung and colon. The physiological im-
portance for this observation is still un-
clear. IL-22 not only is essential for
host defense against invading patho-
gens, but it also controls the spectrum
of commensal bacteria in the intestine
(Sonnenberg et al., 2012). For example,
IL-22 limits the presence of segmented
filamentous bacteria (SFB) in the small in-
testine (Upadhyay et al., 2012). Therefore,it seems reasonable to assume that the homeostatic expression
of IL-18, controlled by IL-22, is important in shaping the intestinal
microflora, which is consistent with alterations in commensal
bacteria when the IL-18 pathway is abrogated (Elinav et al.,
2011).
Both CD4+ Th cell subsets and ILCs aremajor sources of IL-22
in intestinal inflammation (Rutz et al., 2013). In this study, we
found that ILCs but not T cells were the dominant source of IL-
22 in the ileum during T. gondii infection. Previous studies had
identified IL-23 as the upstream cytokine to promote IL-22
expression in the model (Mun˜oz et al., 2009). We found that IL-
22 induction was compromised in IL-18-deficient mice, suggest-
ing a critical role for IL-18 in regulation of IL-22 production. In
addition to its effects on Th1 cells in promoting IFN-g production,
IL-18 can induce the expression of many other pro-inflammatory
cytokines and activate different cells such as neutrophils, NK
cells, and other Th cells, including Th17 cells (Dao et al., 1998;
Leung et al., 2001; Mathur et al., 2007; Nakanishi et al., 2001;
Xu et al., 1998). Although it has been reported that IL-18 induces
IL-22 expression fromNK cells (Zenewicz et al., 2008), the role of
IL-18 in regulation of IL-22 in T cells and ILCs is not well charac-
terized. In the present study, we demonstrate that IL-22 produc-
tion from memory Th cell subsets is significantly enhanced upon
IL-18 stimulation. Furthermore, we found that IL-18 synergizes
with IL-23 to induce IL-22 production from fully differentiated
Th17 and Th22 cells even without TCR stimulation. Most impor-
tantly, IL-18 synergizes with IL-23 to enhance IL-22 production
from ILCs. These data suggest that IL-18 not only drives Th1-
cell-mediated immunity, but also amplifies the IL-22 pathway
to form a feedback loop that contributes to inflammation and tis-
sue damage in the small intestine during T. gondii infection.
In conclusion, we have identified a cross-talk between IL-18
and IL-22 in intestinal inflammation. IL-22 directly induces
IL-18 expression in intestinal epithelial cells, which not only is
essential for host defense but also contributes to inflammation.
Especially during T. gondi-induced ileitis, the positive feedback
loop between IL-18 and IL-22 drives small intestinal inflamma-
tion and necrosis. Our findings provide mechanistic insights
into the physiological role of IL-18 and IL-22 in host defense,
maintenance of homeostasis in the intestinal environment, and
inflammatory diseases.
EXPERIMENTAL PROCEDURES
T. gondii, Infection, Sampling Procedure, and Histological Score
Cysts of the T. gondiiME49 strain were obtained from brains of NMRI mice in-
fected with 10 cysts for 2–3 months. Mice were infected with 100 cysts in
0.3 ml of PBS by gavage. All animal experiments were conducted according
to the German animal protection laws as well as the Genentech Institutional
Animal Care and Use Committee. Histological scores and parasite loads
were determined in formalin-fixed and paraffin-embedded tissue sections
taken from the terminal ileum as described previously (Heimesaat et al., 2006).
Detection of T. gondii
1 cm of ileum tissue was homogenized in a rotor-stator in 500 ml lysis buffer
containing 100 mM Tris HCl (pH 8.0), 200 mM NaCl, 5 mM EDTA, 0.2%
SDS, and 200 mg/ml proteinase K. The amplification was done with the Light-
Cycler FastStart Master Hybridization Probes kit (Roche). Fluorescence was
analyzed by LightCycler Data Analysis software 3.5 (Roche).
C. rodentium Infection
C. rodentium was cultured in Luria broth overnight and mice were inoculated
orally with 2 3 109 colony-forming units of bacteria as described (Zheng
et al., 2008).
Generation of Gnotobiotic Mice and Fecal Transplantation
To generate gnotobiotic mice, conventional C57BL/6 mice were bred and
maintained under specific-pathogen-free (SPF) conditions in the facilities of
the ‘‘Forschungseinrichtung fu¨r Experimentelle Medizin’’ (FEM, Charite´ - Uni-
versita¨tsmedizin, Berlin, Germany). The commensal intestinal microbiota
was eradicated by treating themice with antibiotics then reconstituted by fecal
transplantation. Details are provided in the Supplemental Experimental
Procedures.
In Vivo Stimulation
Mice were injected i.p. with IL-22-mIgG2a (IL-22-Fc, 100 mg/dose, Genentech
PRO312045) or equivalent amount of control protein, 3 mg ultra-pure flagellin
(tlrl-flic, InvivoGen), 100 mg/dose of LPS (Sigma), or recombinant mouse
IL-18 (B004-2; MBL).
Ex Vivo Culture Stimulation
Ileal sections (1 cm) were washedwith PBS and incubated in 2ml of RPMI con-
taining penicillin, streptomycin, and mouse rIL-22 (ML-010; R&D Systems,
100 ng/ml) for 1, 2, 6, and 24 hr, or mouse rIL-18 (B004-2; R&D Systems,
10 ng/ml) for 36 hr at 37C. For dose-dependent stimulation, ileal cultures
were stimulated with 10, 25, 50, and 100 ng/ml of recombinant mouse IL-22
for 2 hr at 37C. For detection of basal amounts of IL-18 or after in vivo stim-
ulation with IL-22-Fc, ileal sections (3 cm) were incubated overnight at 37C.Lamina Propria Cell Isolation and Flow Cytometry
The small intestine, dissected from its mesentery and Peyer’s patches, was
cut into 1-cm-long pieces and incubated in 5 mMEDTA, 1 mMDTT (Sigma-Al-
drich) in RPMI 1640. Pieces were then incubated in RPMI containing 500 mg/ml
liberase CI (Roche) and 0.05%DNase. Cells were stimulated with 50 ng/ml 12-
O-tetradecanoylphorbol-13 acetate (Sigma), 750 ng/ml ionomycin (Sigma),
and Golgi Stop (BD Biosciences) for 4 hr at 37C. Cells were then stained
with anti-CD4 (L3T4 clone), anti-CD8 (53-6.7 clone), anti-CD11b (PK136
clone), Ly6C/G (1A8 clone), IFN-g (XMG1.2 clone, all from BD Biosciences),
and anti-IL-22 (Genentech). Cells were analyzed either with a FACSCalibur
or LSR II Flow Cytometer (BD Biosciences).
Stimulation of Splenocytes and ILCs
For ILC isolation, the small intestine, dissected from its mesentery and Peyer’s
patches from Rag2-deficient mice, was cut into 1-cm-long pieces and incu-
bated in HBSS with 2% FBS, 10 mM HEPES, 1 mM EDTA, and 2 mM DTT
and shaken at 200 rpm for 40 min. After vortex for 10 s, the intestinal pieces
were washed in HBSS with 2% FBS, 10 mM HEPES before being minced
in HBSS with 2% FBS, 10 mM HEPES, 0.1 mg/ml Liberase TM, and
0.15 mg/ml DNase I (Roche) and incubated for 30 min under agitation. Enzyme
activity was inhibited by addition of DMEM, 10% FBS. The cell suspensions
were filtered and resuspended in 31.5% Percoll overlayed on 72% Percoll.
Cells from the interface were isolated and further purified with the Dead Cell
Removal Kit (Miltenyi) followed by a CD45 enrichment (CD45 MicroBeads
[Miltenyi]). Cells were sorted by flow cytometry for Lin (NK1.1, CD8a, CD3,
TCRgd, CD11c, B220), CD45+CD117+CD127+ (all from eBioscience).
For stimulation, splenocytes or isolated ILCs from Rag2-deficient mice were
stimulated in the presence of IL-18 (20 ng/ml) (MLB), IL-23 (20 ng/ml) (R&D), or
both for 48 hr.
Organoid Culture
Small intestinal organoids were generated from wild-type C57BL/6 mice and
IL-22R1-deficient mice (Sato et al., 2009). The entire small intestine was
flushed with PBS, opened longitudinally, cut into 2 mm sections, and incu-
bated in Hank’s buffer (Invitrogen) in 2 mM EDTA and 1 mM DTT at 4C for
30min. Intestinal crypts were shed and isolated via vigorous pipetting of tissue
in PBS. Crypts (500–1000) were then embedded in a 50 ml matrigel plug (BD
Biosciences) and cultured in Advanced DMEM/F12 media supplemented
with penicillin and streptomycin, 10 cmM HEPES, Glutamax, 1x N-2 & B27
supplements (Invitrogen), 1 cmM N-acetylcysteine (Sigma), and the following
growth factors (peprotech): EGF (50 ng/ml), noggin (100 ng/ml), and R-spondin
(1 mg/ml). For qRT-PCR analysis, organoids were stimulated with either PBS or
100 ng/ml of mouse IL-22 (R&D Systems). The cytokines were added to the
culture media. At the indicated time points, cells were incubated with Dispase
(BD Biosciences) for 30min, pelleted, and resuspended in Trizol. RNAwas iso-
lated via the Trizol plus RNA purification kit (Invitrogen). cDNA was generated
with the Vilo cDNA synthesis kit and TaqMan assay was performed with the
TaqMan Universal PCR Master mix (Biorad) per manufacturer’s instructions.
Scraping of Intestinal Epithelial Cells
2 cmof duodenum, jejunum, or ileumwere cut open. Epitheliawere scrapedwith
a razor blade. Isolated epithelial cells were incubated in RPMI at 4C for 60 min.
Cells were then lysed with SDS sample buffer and boiled for WB analysis.
T Cell Purification and Culture
Naive CD4+ T cells were purified by pre-enrichment of CD4+ T cells from
spleens and lymph nodes bymagnetic-activated cell sorting (CD4MicroBeads;
Miltenyi Biotec) and sorting by flow cytometry for CD4+CD45RbhiCD44loCD25
T cells (FACSAria; BD Biosciences) after staining with anti-CD4 (RM4-5),
anti-CD45Rb (16A), anti-CD44 (IM-7), and anti-CD25 (PC61; all fromBDBiosci-
ences). Naive T cells were cultured in presence of anti-CD3, anti-CD28 and
under polarization conditions for Th0, Th1, Th17, and Th22 cell-associated sub-
sets. Details are provided in the Supplemental Experimental Procedures. Su-
pernatants were harvested for ELISA 3 days after stimulation.
Macrophage Activation
Mice were injected i.p. with 1 ml of thioglycollate. 4 days later, macrophages
were harvested by peritoneal lavage. Cells were cultured in DMEM, 10%Immunity 42, 321–331, February 17, 2015 ª2015 Elsevier Inc. 329
FCS for 1 hr to allow full adhesion of macrophages. Wells were gently washed
with media to remove any non-adherent cells. Then LPS (L3012; Sigma) was
added for 6 hr at 250 ng/ml, followed by the addition of nigericin (tlrl-nig; Invi-
trogen) for 1 hr at 5 mg/ml. Supernant was concentrated with centrifugation fil-
ter units (Amicon; UFC800324) by centrifugation for 1.30 hr at 750 3 g for
further analysis by immunoblot analysis.
Real-Time PCR
mRNA was isolated from ilea, colon, spleen, and lungs with the RNeasy Mini
Kit (QIAGEN). Reactions to detect Il18 mRNA were performed with Super
Script II/Platinum Taq Master Mix using Light Cycler Data Analysis Software
(Roche). Expression of the gene of interest was calculated relative to Hprt
expression.
In addition, mRNA amounts of Il18, Il22, Reg3b, and Reg3g were measured
by real-time RT-PCR with TaqMan One-Step RT-PCR Master Mix reagents
(Applied Biosystems) and the appropriate primers and probes. Results were
normalized to those of the control housekeeping gene Rpl19 (encoding ribo-
somal protein L19) and are reported as 2DCT.
Immunoblot Analysis
Proteins (30 mg per lane, measured by bicinchoninic acid assay [Pierce]) were
separated by SDS-PAGE through 4%–12% (vol/vol) Novex Tris-Glycine gels
(Invitrogen), transferred to nitrocellulose membranes, and analyzed by immu-
noblot. Membranes were blocked for 1 hr at 20C in 5% (vol/vol) milk in TBST
(10 mM Tris [pH 7.5], 150 mM NaCl, 0.1% [vol/vol] Tween-20), probed over-
night at 4C in blocking buffer with anti-IL-18 (5180R; Biovision) or rabbit poly-
clonal anti-b-actin (A2066; Sigma-Aldrich), washed in TBST, and incubated at
20C with horseradish peroxidase-conjugated anti-rabbit (7074). Proteins
were visualized with SuperSignal West Pico chemiluminescent substrate
(Pierce).
Cytokine ELISA
Concentrations of IFN-g (cat. no. 558258), IL-6 (cat. no. 550950), IL-1b (cat. no.
559603; all from BD OptEIA Mouse ELISA kit), IL-22 (R&D Systems, in house
Genentech), and IL-18 (KMC0181 [Invitrogen] or 7625 [MBL]) were determined
in supernatants of organ cultures according to the manufacturer’s protocols.
IL-22 ELISA was performed as previously described (Zheng et al., 2007) via
monoclonal anti-IL-22 antibodies (20E5 and 14B7, Genentech).
Immunohistochemical Staining
4-mm sections were cut, deparaffinized, and subjected to heat-induced
epitope retrival step before incubation with MPO7 (A0398, Dako, 1:500) and
IL-18 (M-19, sc-6179, Santa Cruz, 1:20) antibodies. Sections were immersed
in cool running water, washed in TBS, and incubated with primary antibodies.
For detection, Streptavidin-AP kit and Envision PO kit (both Dako) were used.
Images were acquired with fluorescent microscope equipped with a charge-
couple device (CCD) camera (AxioCam MRm) and processed with Axiovision
software (Carl Zeiss MicroImaging). For MPO staining, negative controls were
performed by omitting the primary antibodies and positive cells were quanti-
fied in tissues per high-power field.
For IL-18 staining after IL-22-Fc injection, tissues were processed and
embedded in paraffin, and 5 mmsections of tissues were obtained by standard
histological procedures. Immunohistochemistry were performed with Ventana
Discovery XT automated system (Ventana Medical Systems). Slides were de-
paraffinized on the automated system with EZ Prep solution (Ventana). Heat-
induced antigen retrieval was performed with Cell Conditioning 1 Standard
(CC1s) (Ventana). Endogenous peroxidases were quenched with the inhibi-
tor-D proprietary reagent (Ventana) for 4 min. Primary antibody IL-18 (Bio-
Vision) was used at 1:500 diluted in PBS containing 3% bovine serum albumin
(Roche) and incubated for 60 min at 37C. The detection system used was the
Omni-Map anti-Rabbit, HRP for 32 min and ChromaMap DAB (Ventana).
Slides were then counterstained with Ventana Hematoxylin II for 4 min, blueing
for 4 min, dehydrated, and coverslipped.
Genome-wide Expression Analysis
Raw Affymetrix files were pre-processed and normalized with R (http://www.
r-project.org/) and Bioconductor (http://www.bioconductor.org) software.
Normalization was done with RMA. Limma package was used to calculate dif-330 Immunity 42, 321–331, February 17, 2015 ª2015 Elsevier Inc.ferential expression p values between samples from wild-type and gene-defi-
cient mice. The Benjamini-Hochberg method was used for multiple test
correction and per-gene p values. Differentially expressed genes were identi-
fied at FDR of 0.01, with a minimum 4-fold change between wild-type and IL-
22-deficient samples.
Statistical Analyses
Student’s t test or 2-ways ANOVA test (for analysis of body weight loss) were
performed, as indicated. Probability (p) values of <0.05 were considered sig-
nificant: *p < 0.05; **p < 0.01; and ***p < 0.001.
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